Mersana Therapeutics (0M4.F) Q1 2025 Earnings

3MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.18
-0.15
-0.12
-0.09

Details

Expected EPS
-0.15272126409
Actual EPS
-0.1049257
Surprise EPS
0.05
Surprise Percent
+31.3%

Description

Mersana Therapeutics (0M4.F) has reported earnings of -0.1049257 per share for Q1 2025.

0 Comments

Share your thoughts